[Influence of ovulation inhibitors on clinicochemical norms].
D000305:Adrenal Cortex Hormones / Q000097:blood; D000328:Adult; D001798:Blood Proteins / Q000032:analysis*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D002624:Chemistry, Clinical; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003300:Copper / Q000097:blood; D004573:Electrolytes / Q000097:blood; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008099:Liver / Q000201:enzymology; D008875:Middle Aged; D011372:Progestins / Q000494:pharmacology; D013975:Thyroxine-Binding Proteins / Q000032:analysis; D013997:Time Factors; D014168:Transferrin / Q000032:analysis
D000305:Adrenal Cortex Hormones; D001798:Blood Proteins; D003276:Contraceptives, Oral; D004573:Electrolytes; D011372:Progestins; D013975:Thyroxine-Binding Proteins; D014168:Transferrin; D004997:Ethinyl Estradiol; D003300:Copper; D002097:C-Reactive Protein; D002570:Ceruloplasmin
Einfluss oraler Ovulationshemmer auf klinisch-chemische Normalwerte.